5530 Wisconsin AvenueSte 650Bethesda, MD 20815
Fax+1 202-223-2622
Overview of Dr. Ginsberg
Dr. Sandra Ginsberg is an oncologist in Bethesda, MD and is affiliated with multiple hospitals in the area, including George Washington University Hospital and MedStar Georgetown University Hospital. She received her medical degree from University of Chicago Division of the Biological Sciences The Pritzker School of Medicine and has been in practice 45 years. Dr. Ginsberg accepts several types of health insurance, listed below. She is one of 39 doctors at George Washington University Hospital and one of 98 doctors at MedStar Georgetown University Hospital who specialize in Oncology. She has more than 20 publications and over 500 citings.
Education & Training
SUNY Upstate Medical UniversityFellowship, Hematology and Medical Oncology, 1976 - 1977
University of WashingtonFellowship, Hematology and Medical Oncology, 1975 - 1976- SUNY Upstate Medical UniversityResidency, Internal Medicine, 1973 - 1975
University of ChicagoInternship, Internal Medicine, 1972 - 1973
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1972
Certifications & Licensure
DC State Medical License 1992 - 2026
MD State Medical License 2010 - 2026
NY State Medical License 1973 - 1994
WA State Medical License 1975 - 1976
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 20 citationsA randomized comparison of methotrexate dose and the addition of bleomycin to chop therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas cancer and...Arlan J. Gottlieb, James R. Anderson, Sandra J. Ginsberg, Clara D. Bloomfield, Larry Norton
Cancer. 1990-11-01 - 7 citationsPhase II study of iproplatin (CHIP) in previously treated small-cell lung cancer.James M. Granfortuna, Nancy Newman, Sandra J. Ginsberg, Arthur Louie, Robert L. Comis
American Journal of Clinical Oncology. 1989-08-01 - 13 citationsA phase II trial of iproplatin (CHIP) in previously treated advanced breast cancer.Dennis J. Meisner, Sandra J. Ginsberg, Allan Ditch, Arthur Louie, Nancy Newman
American Journal of Clinical Oncology. 1989-04-01
Professional Memberships
- Member
Insurance Accepted
- Aetna Choice POS II
BCBS Blue Card PPO
CareFirst BCBS Maryland POS
CareFirst BluePreferred PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPOFirst Health PPO
Great West PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
